This site is intended for Healthcare Professionals only

Incorrect username and/or password, please try again or click to reset.

Class 4 Medicines Defect Information: Novartis Pharmaceuticals, Simulect 10mg & 20mg powder and solvent for Solution for injection or infusion, EL (23)A/17

2023-05-16 12:58:47 (2 year(s) ago)

Summary

Novartis Pharmaceuticals has informed the MHRA that the solvent (water for injections in ampoules) co-packed with the impacted batches of Simulect powder for injection, may contain glass fragments approximately 20 – 800 µm i…

Read full MHRA article

Respond to this alert

Sign up for your FREE ticket to see PharmData at the Pharmacy Show to see our latest products and features demonstrated live!